Page last updated: 2024-10-24

chlorambucil and Anorectal Diseases

chlorambucil has been researched along with Anorectal Diseases in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, SW1
Scarrow, GD1
Macaulay, MB1

Other Studies

1 other study available for chlorambucil and Anorectal Diseases

ArticleYear
Multiple lymphomatous polyposis of the gastro-intestinal tract.
    The British journal of surgery, 1970, Volume: 57, Issue:2

    Topics: Chlorambucil; Colitis, Ulcerative; Colonic Diseases; Diagnosis, Differential; Folic Acid; Hodgkin Di

1970